The abstracts of the CTAD are available in PDF format, you can download them on

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

The abstracts of the ICFSR are available in PDF format, you can download them on this link

this link

News, News Plasma biomarker for Alzheimer’s disease: Are we ready now for clinical practice and drug trials?

To facilitate disease-modifying clinical trials for Alzheimer’s Disease (AD), a blood-based amyloid-β (Aβ) biomarker, which can accurately detect an early pathological signature of AD at prodromal or preclinical stages, has been strongly desired, because it is simpler, less invasive and… Continue Reading →

News What Have We Learned from Recent Alzheimer’s Trials? Perspective of the CTAD Task Force

Although the results were disappointing from two recent clinical trials of amyloid-targeting drugs in mild-to-moderate AD, the trials provided information that will be important for future studies, according to the EU-US CTAD Task Force, which met in November 2017 to… Continue Reading →

News The design and rationale of the ENRGISE study

This symposium was presented at ICFSR 2018 (Miami Beach, USA, 1-3 March 2018). Enabling Reduction of low-Grade Inflammation in Seniors -Pilot Study. The ENRGISE Pilot Studywill provide preliminary data to design a definitive clinical trial to assess whether the reduction… Continue Reading →

« Older posts

© 2018 Aging-news — Powered by WordPress

Theme inspired by Anders NorenUp ↑